anakinrasevere dengueCytokine stormsecondary haemophagocytic lymphohistiocytosisplasmapheresis
…021 and December 2023 with confirmed severe dengue who received anakinra. Cytokine storm was suspected based on clinical and laboratory …
16articles mentioning drugs
31drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Anakinra ×
Anakinra
This drug is selected. Its supporting articles are shown below.
Articles mentioning Anakinra
16 articles · page 1 of 2eculizumabrituximabanakinracaplicazumabcaplacizumabmethylprednisoloneeculizumumabIV cyclophosphamidesystemic lupus erythematosusSLE+1 more
… immunomodulation with combination targeted biologics—including eculizumab—may achieve full end-organ recovery despite life-threatening im…
anakinratocilizumabdapsonecotrimoxazolepentamidinemethylprednisoloneascorbic aciddapsone-inducedAdult-onset Still’s disease (AOSD)Pneumocystis jirovecii pneumonia+3 more
… a tapering regimen at 1 mg/Kg/day), tocilizumab (8 mg/kg), and anakinra (200 mg/day). The clinical pharmacist followed the patient thro…
ruxolitinibemapalumabetoposidetocilizumabanakinraprednisoneadult-onset Still’s diseaseautoinflammatory diseasemacrophage activation syndrome (MAS)anti-interleukin-1 therapy
…ory values. The patient was then discharged on a stable dose of ruxolitinib, anakinra and prednisone. This case illustrates the therapeutic…
anakinraaspirinKawasaki diseaseintravenous immunoglobulincoronary artery aneurysms
…venous immunoglobulin and aspirin. The patient was treated with anakinra, an interleukin-1 receptor antagonist, which improved inflammat…
vilobelimabbaricitinibtocilizumabanakinraremdesivirmolnupiravirconvalescent plasmanirmatrelvirritonavir
…aricitinib (n=2), convalescent plasma (n=1), anakinra (n=1) and vilobelimab (n=1)). DISCERN (median (IQR)) reliability was 4 (IQR 3–4) and …
anakinrasystemic juvenile idiopathic arthritisStill’s diseasesJIAtertiary paediatric rheumatology centreILD
…h were independently associated with a polycyclic course. Early anakinra initiation was more frequent in severe cases but was not indepe…
axicabtagene ciloleuceltisagenlecleucelciltacabtagene autoleucelanakinramultiple myelomaDLBCLacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANSOrionClinic+1 more
…in over one-third of patients, especially in DLBCL treated with axicabtagene ciloleucel, while none were reported with tisagenlecleucel. Despite low mo…
axi-celAxicabtagene ciloleucelsiltuximabdexamethasonemethylprednisoloneanakinratocilizumabDiffuse large B-cell lymphoma (DLBCL)DLBCLnon-Hodgkin lymphomas
…mplications.Conclusion and Relevance In this real-world cohort, axi-cel showed predictable but significant toxicity, including universa…
lamotrigineanakinraimmunoglobulinUS Food and Drug AdministrationHaemophagocytic lymphohistiocytosisintravenous corticosteroidsHLH
… with intravenous corticosteroids, immunoglobulin and anakinra; lamotrigine was withdrawn. Both patients recovered fully following protract…
hydroxychloroquineprednisoloneanakinraIL-1 blockadesystemic lupus erythematosusSLE
…eous, articular e serosae involvement, on baseline therapy with hydroxychloroquine 200 mg/day and prednisolone 10 mg/day due to recent flare with …
hydroxychloroquinerituximabanakinraHCQRTXsystemic lupus erythematosusHemophagocytic lymphohistiocytosisRheumatology Department
…d ( table 1). Case 1: A 27-year-old female with SLE, who was on hydroxychloroquine (HCQ) and rituximab (RTX), was admitted with an axillary absces…